Alternatives to BIOCAPTIVA

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Natera is a global leader in cell-free DNA testing, providing genetic testing services for reproductive health, oncology, and organ transplantation.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

A vertically-integrated procurement platform for the life sciences industry.

A global leader in clinical pharmacology and bioanalytical sciences.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

AI-powered knowledge discovery for life sciences.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Biotechnology startup using genetically engineered insects to convert organic waste into high-value recombinant proteins.

Revolutionizing genomic analysis with innovative sequencing technology.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Pioneering vision restoration therapies for severe retinal degenerations.

Developing non-invasive ultrasound neuromodulation therapies for chronic immune-mediated diseases and inflammatory disorders.

Wilbe provides flexible lab infrastructure and services for science startups.

Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.